Torthaí cuardaigh - Sarah Kenny
- 1 - 11 toradh as 11 á dtaispeáint
-
1
Longitudinal Links Between Fathers’ and Mothers’ Harsh Verbal Discipline and Adolescents’ Conduct Problems and Depressive Symptoms de réir Ming‐Te Wang, Sarah Kenny
Foilsithe / Cruthaithe 2013Artigo -
2
-
3
Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience de réir Richard Adams, Angela Meade, Ayman Madi, David J. Fisher, Edward Kay, Sarah Kenny, Richard Kaplan, Tim Maughan
Foilsithe / Cruthaithe 2009Artigo -
4
Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease de réir Claire Healy, Natalia Muñoz‐Wolf, Janné Strydom, Lynne Faherty, Niamh C. Williams, Sarah Kenny, Seamas C. Donnelly, Suzanne M. Cloonan
Foilsithe / Cruthaithe 2021Revisão -
5
Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab de réir Christopher G. Smith, David J. Fisher, Bart Claes, Tim Maughan, Shelley Idziaszczyk, Gilian Peuteman, Rebecca Harris, Michelle D. James, Angela Meade, Bharat Jasani, Richard Adams, Sarah Kenny, Richard Kaplan, Diether Lambrechts, Jeremy P. Cheadle
Foilsithe / Cruthaithe 2013Artigo -
6
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenop... de réir Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar
Foilsithe / Cruthaithe 2017Artigo -
7
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenop... de réir Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar
Foilsithe / Cruthaithe 2020Artigo -
8
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M... de réir Richard Adams, Angela Meade, Michel Seymour, Richard H. Wilson, Ayman Madi, David J. Fisher, Sarah Kenny, Edward Kay, Elizabeth Hodgkinson, Malcolm Pope, P. Rogers, Harpreet Wasan, Stephen Falk, Simon Gollins, Tamas Hickish, E.M. Bessell, David Propper, Megan Kennedy, Richard Kaplan, Tim Maughan
Foilsithe / Cruthaithe 2011Artigo -
9
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial de réir Tim Maughan, Richard Adams, Christopher G. Smith, Angela Meade, Michel Seymour, Richard H. Wilson, Shelley Idziaszczyk, Rebecca Harris, David J. Fisher, Sarah Kenny, Edward Kay, Jenna Mitchell, Ayman Madi, Bharat Jasani, Michelle D. James, John Bridgewater, Megan Kennedy, Bart Claes, Diether Lambrechts, Richard Kaplan, Jeremy P. Cheadle
Foilsithe / Cruthaithe 2011Artigo -
10
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis de réir Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette C. Siaton, Benjamin J. Smith, Abby S. Van Voorhees, A. Helena Jonsson, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice B. Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, Jose U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner, James Reston
Foilsithe / Cruthaithe 2018Artigo -
11
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis de réir Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette C. Siaton, Benjamin J. Smith, Abby S. Van Voorhees, A. Helena Jonsson, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice B. Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, Jose U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner, James Reston
Foilsithe / Cruthaithe 2018Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Cancer
Oncology
Chemotherapy
Colorectal cancer
Pathology
Cetuximab
Confidence interval
Disease
Environmental health
Hazard ratio
Oxaliplatin
Surgery
Abatacept
Aromatase inhibitor
Biology
Breast cancer
Capecitabine
Enthesitis
Epidermal growth factor receptor
Guideline
Immunology
Intensive care medicine
Lapatinib
Lymphoma
Physical therapy
Population
Psoriatic arthritis
Randomized controlled trial